gemcitabinePancreatic ductal adenocarcinoma (PDAC)chemotherapyimmunotherapy
…on. Moreover, MPO inhibition or deficiency sensitized tumors to gemcitabine, highlighting a synergistic effect with chemotherapy. Complemen…
32articles mentioning drugs
70drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Gemcitabine ×
Gemcitabine
This drug is selected. Its supporting articles are shown below.
Articles mentioning Gemcitabine
32 articles · page 3 of 3gemcitabinegemcitabine-basedPancreatic cancerWest Virginia UniversitychemotherapyFOLFIRINOX
… be more prominent in patients receiving FOLFIRINOX rather than gemcitabine/nab-paclitaxel treatment. Further, preliminary analysis suggest…
mirvetuximab soravtansinegemcitabineexatecanClone 65FDAplatinum-resistant ovarian cancerrecurrent diseaseepithelial ovarian cancersSanyou Biopharmaceuticals Laboratory Animal Ethics CommitteeSKOV3
…sis, achieved superior tumor growth inhibition and outperformed mirvetuximab soravtansine. Our data highlights the therapeutic potential and tolerability…
pembrolizumabgemcitabinesplit-dose cisplatinimmunotherapyLynch syndromestage I colon cancerLS
… cancer. An initial attempt to obtain an insurance approval for pembrolizumab given LS and context of deficient mismatch repair was unsuccess…
gemcitabinecisplatincapecitabinefluorouracilnasopharyngeal carcinomaMiao et alLiu et alLA-NPCinduction chemotherapyadjuvant chemotherapy+1 more
… compared two intravenous adjuvant regimens, demonstrating that gemcitabine plus cisplatin (GP) outperformed the traditional fluorouracil p…
capecitabinegemcitabinecisplatinfluorouracilpaclitaxelSun Yat-sen University Cancer Centernasopharynx carcinomanasopharyngeal carcinomaLA-NPCCCRT
…from 50% to 70%3 7 8 for intravenous AC and 70% to 80% for oral capecitabine.1 2 This cohort offers valuable insights into real-world experi…
gemcitabineGemcitabineABRaxaneIRInotecanOXaliplatine-2GEMBRAXnab-paclitaxelPancreatic adenocarcinomaFFXmPCFOLFIRINOXFrench National Agency for the Safety of Health Products
…revious phase Ib-II trial, we evaluated a sequential regimen of gemcitabine plus nab-paclitaxel (GEMBRAX) followed by FOLFIRINOX (FFX), whi…
capecitabineS-1cisplatintegafurgimeracilgemcitabinefluorouraciloteracil potassium capsulenasopharyngeal carcinomaCCRT
…induction chemotherapy and CCRT, oral chemotherapy, either with capecitabine or S-1, was efficacious and tolerable.…